Concepedia

Kaoru Yamagami

KY

6

Publications

165

Citations

6

H-Index

2003

Active since

Affiliations

Astellas Pharma (Japan)(Current)

Kaoru Yamagami is an author at Astellas Pharma (Japan) specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryPharmacotherapyImmunologyBiochemistryInflammationAsthmaAllergyChemistry

Publications per year

2003–2018

6

Publications

6

A novel JAK inhibitor, peficitinib, demonstrates potent efficacy in a rat adjuvant-induced arthritis model

Misato Ito, Shunji Yamazaki, Kaoru Yamagami et al. · Journal of Pharmacological Sciences · 2016 · 91 citations · Full text

Immunology, Pharmacotherapy, Inflammation +17

Pharmacological profile of FK881(ASP6537), a novel potent and selective cyclooxygenase-1 inhibitor

Junko Imanishi, Yoshiaki Morita, Eiji Yoshimi et al. · Biochemical Pharmacology · 2011 · 23 citations

Molecular Pharmacology, Anti-inflammatory, Biochemistry +9

Discovery and biological evaluation of novel pyrazolopyridine derivatives as potent and orally available PI3Kδ inhibitors

Toshihiro Hamajima, Fumie Takahashi, Koji Kato et al. · Bioorganic & Medicinal Chemistry · 2018 · 15 citations · Full text

Medicinal Chemistry, Biochemistry, Novel Pyrazolopyridine Derivatives +11

[2+2] photodimerization of (E)-styrylthiazoles through cation–π-controlled preorientation

Shinji Yamada, Kaoru Yamagami, Saki Oaku · Tetrahedron Letters · 2016 · 13 citations

Engineering, Photochemistry, Mechanistic Photochemistry +4

THU0101 ASP015K: A Novel Jak Inhibitor Demonstrated Potent Efficacy in Adjuvant-Induced Arthritis Model in Rats

S. Yamazaki, Hiroki Morio, Masamichi Inami et al. · Annals of the Rheumatic Diseases · 2013 · 12 citations

Rows per page

1–5 of 6